HCPCS Level II · Drugs administered other than oral method
J0224Injection, lumasiran, 0.5 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J0224
J0224 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, lumasiran, 0.5 mg.
It was added to HCPCS effective 07/01/2021.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj. lumasiran, 0.5 mg
- Date added
- 07/01/2021
- Action effective
- 07/01/2021
- BETOS
- O1E
Related J02xx codes
- J0202Injection, alemtuzumab, 1 mg
- J0206Injection, allopurinol sodium, 1 mg
- J0207Injection, amifostine, 500 mg
- J0208Injection, sodium thiosulfate (pedmark), 100 mg
- J0209Injection, sodium thiosulfate (hope), 100 mg
- J0210Injection, methyldopate hcl, up to 250 mg
- J0211Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
- J0216Injection, alfentanil hydrochloride, 500 micrograms
- J0217Injection, velmanase alfa-tycv, 1 mg
- J0218Injection, olipudase alfa-rpcp, 1 mg
- J0219Injection, avalglucosidase alfa-ngpt, 4 mg
- J0220Injection, alglucosidase alfa, 10 mg, not otherwise specified
Common questions about J0224
Is HCPCS J0224 still valid?
- Yes. J0224 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J0224?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.